You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19—Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)
|
---|---|
Published in |
Frontiers in Pharmacology, July 2022
|
DOI | 10.3389/fphar.2022.870493 |
Pubmed ID | |
Authors |
M. Karolyi, E. Pawelka, S. Omid, F. Koenig, V. Kauer, B. Rumpf, W. Hoepler, A. Kuran, H. Laferl, T. Seitz, M. Traugott, V. Rathkolb, M. Mueller, A. Abrahamowicz, C. Schoergenhofer, M. Hecking, A. Assinger, C. Wenisch, M. Zeitlinger, B. Jilma, A. Zoufaly |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Austria | 1 | 25% |
United Kingdom | 1 | 25% |
United States | 1 | 25% |
Unknown | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 3 | 75% |
Members of the public | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 17 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Doctoral Student | 3 | 18% |
Student > Master | 2 | 12% |
Student > Ph. D. Student | 1 | 6% |
Researcher | 1 | 6% |
Student > Bachelor | 1 | 6% |
Other | 2 | 12% |
Unknown | 7 | 41% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 29% |
Unspecified | 1 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Environmental Science | 1 | 6% |
Nursing and Health Professions | 1 | 6% |
Other | 1 | 6% |
Unknown | 7 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2023.
All research outputs
#14,988,355
of 23,971,024 outputs
Outputs from Frontiers in Pharmacology
#5,102
of 17,641 outputs
Outputs of similar age
#207,455
of 436,898 outputs
Outputs of similar age from Frontiers in Pharmacology
#269
of 1,309 outputs
Altmetric has tracked 23,971,024 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,641 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,898 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,309 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.